IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD Meeting Abstract


Authors: Lindemans, C. A.; Mertelsmann, A.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; Luo, N.; Ivanov, J.; Hua, G.; Martin, M. L.; Liu, C.; Kolesnick, R.; Van Den Brink, M.; Hanash, A. M.
Abstract Title: IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242700094
PROVIDER: wos
Notes: Meeting Abstract: 651 -- Source: Wos